Literature DB >> 28395083

Pathological Confirmation of Optic Neuropathy in Familial Dysautonomia.

Carlos E Mendoza-Santiesteban1,2,3, Jose-Alberto Palma2, Thomas R Hedges1, Nora V Laver1, Nada Farhat1, Lucy Norcliffe-Kaufmann2, Horacio Kaufmann2.   

Abstract

Clinical data suggest that optic neuropathy and retinal ganglion cell loss are the main cause of visual decline in patients with familial dysautonomia, but this has not previously been confirmed by pathological analyses. We studied retinas and optic nerves in 6 eyes from 3 affected patients obtained at autopsy. Analyses included routine neurohistology and immunohistochemistry for neurofilaments, cytochrome c oxidase (COX), and melanopsin-containing ganglion cells. We observed profound axon loss in the temporal portions of optic nerves with relative preservation in the nasal portions; this correlated with clinical and optical coherence tomography findings in 1 patient. Retinal ganglion cell layers were markedly reduced in the central retina, whereas melanopsin-containing ganglion cells were relatively spared. COX staining was reduced in the temporal portions of the optic nerve indicating reduced mitochondrial density. Axonal swelling with degenerating lysosomes and mitochondria were observed by electron microscopy. These findings support the concept that there is a specific optic neuropathy and retinopathy in patients with familial dysautonomia similar to that seen in other optic neuropathies with mitochondrial dysfunction. This raises the possibility that defective expression of the IkB kinase complex-associated protein (IKAP) resulting from mutations in IKBKAP affects mitochondrial function in the metabolism-dependent retinal parvocellular ganglion cells in this condition.
© 2017 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Familial dysautonomia; Hereditary optic neuropathy; Histopathology; Optical coherence tomography; Retina; Riley-Day syndrome

Mesh:

Year:  2017        PMID: 28395083      PMCID: PMC5409127          DOI: 10.1093/jnen/nlw118

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  27 in total

1.  Afferent baroreflex failure in familial dysautonomia.

Authors:  Lucy Norcliffe-Kaufmann; Felicia Axelrod; Horacio Kaufmann
Journal:  Neurology       Date:  2010-11-23       Impact factor: 9.910

Review 2.  Toxic optic neuropathies: an updated review.

Authors:  Andrzej Grzybowski; Magdalena Zülsdorff; Helmut Wilhelm; Felix Tonagel
Journal:  Acta Ophthalmol       Date:  2014-08-27       Impact factor: 3.761

Review 3.  Respiratory aspects of Riley-Day Syndrome: familial dysautonomia.

Authors:  Hanna Channa Maayan
Journal:  Paediatr Respir Rev       Date:  2006-06-05       Impact factor: 2.726

4.  The natural history of OPA1-related autosomal dominant optic atrophy.

Authors:  A C Cohn; C Toomes; A W Hewitt; L S Kearns; C F Inglehearn; J E Craig; D A Mackey
Journal:  Br J Ophthalmol       Date:  2008-07-24       Impact factor: 4.638

5.  Mitochondrial optic neuropathies: additional facts and concepts - response.

Authors:  Alfredo A Sadun; Chiara La Morgia; Valerio Carelli
Journal:  Clin Exp Ophthalmol       Date:  2013-07-16       Impact factor: 4.207

6.  Clinical neuro-ophthalmic findings in familial dysautonomia.

Authors:  Carlos E Mendoza-Santiesteban; Thomas R Hedges; Lucy Norcliffe-Kaufmann; Floyd Warren; Shantan Reddy; Felicia B Axelrod; Horacio Kaufmann
Journal:  J Neuroophthalmol       Date:  2012-03       Impact factor: 3.042

Review 7.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 8.  Melanopsin-expressing retinal ganglion cells: implications for human diseases.

Authors:  Chiara La Morgia; Fred N Ross-Cisneros; Jens Hannibal; Pasquale Montagna; Alfredo A Sadun; Valerio Carelli
Journal:  Vision Res       Date:  2010-08-04       Impact factor: 1.886

Review 9.  Familial dysautonomia: History, genotype, phenotype and translational research.

Authors:  Lucy Norcliffe-Kaufmann; Susan A Slaugenhaupt; Horacio Kaufmann
Journal:  Prog Neurobiol       Date:  2016-06-15       Impact factor: 11.685

10.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

View more
  12 in total

Review 1.  Animal and cellular models of familial dysautonomia.

Authors:  Frances Lefcort; Marc Mergy; Sarah B Ohlen; Yumi Ueki; Lynn George
Journal:  Clin Auton Res       Date:  2017-06-30       Impact factor: 4.435

Review 2.  Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendations.

Authors:  Mikhail Kazachkov; Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Bat-El Bar-Aluma; Christy L Spalink; Erin P Barnes; Nancy E Amoroso; Stamatela M Balou; Shay Bess; Arun Chopra; Rany Condos; Ori Efrati; Kathryn Fitzgerald; David Fridman; Ronald M Goldenberg; Ayelet Goldhaber; David A Kaufman; Sanjeev V Kothare; Jeremiah Levine; Joseph Levy; Anthony S Lubinsky; Channa Maayan; Libia C Moy; Pedro J Rivera; Alcibiades J Rodriguez; Gil Sokol; Mark F Sloane; Tina Tan; Horacio Kaufmann
Journal:  Respir Med       Date:  2018-06-21       Impact factor: 3.415

Review 3.  Chemoreflex failure and sleep-disordered breathing in familial dysautonomia: Implications for sudden death during sleep.

Authors:  Jose-Alberto Palma; Alex Gileles-Hillel; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Auton Neurosci       Date:  2019-02-15       Impact factor: 3.145

4.  ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia.

Authors:  Elisabetta Morini; Dadi Gao; Connor M Montgomery; Monica Salani; Chiara Mazzasette; Tobias A Krussig; Brooke Swain; Paula Dietrich; Jana Narasimhan; Vijayalakshmi Gabbeta; Amal Dakka; Jean Hedrick; Xin Zhao; Marla Weetall; Nikolai A Naryshkin; Gregory G Wojtkiewicz; Chien-Ping Ko; Michael E Talkowski; Ioannis Dragatsis; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2019-03-21       Impact factor: 11.025

5.  Rescue of a familial dysautonomia mouse model by AAV9-Exon-specific U1 snRNA.

Authors:  Giulia Romano; Federico Riccardi; Erica Bussani; Simone Vodret; Danilo Licastro; Isabella Ragone; Giuseppe Ronzitti; Elisabetta Morini; Susan A Slaugenhaupt; Franco Pagani
Journal:  Am J Hum Genet       Date:  2022-07-28       Impact factor: 11.043

6.  Developmental regulation of neuronal gene expression by Elongator complex protein 1 dosage.

Authors:  Elisabetta Morini; Dadi Gao; Emily M Logan; Monica Salani; Aram J Krauson; Anil Chekuri; Yei-Tsung Chen; Ashok Ragavendran; Probir Chakravarty; Serkan Erdin; Alexei Stortchevoi; Jesper Q Svejstrup; Michael E Talkowski; Susan A Slaugenhaupt
Journal:  J Genet Genomics       Date:  2021-12-09       Impact factor: 5.723

Review 7.  [Syndromic Hirschsprung′s disease and its mode of inheritance].

Authors:  Jing-Ru Zhang; Zhi-Bo Zhang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2018-05

8.  Elongator and codon bias regulate protein levels in mammalian peripheral neurons.

Authors:  Joy Goffena; Frances Lefcort; Yongqing Zhang; Elin Lehrmann; Marta Chaverra; Jehremy Felig; Joseph Walters; Richard Buksch; Kevin G Becker; Lynn George
Journal:  Nat Commun       Date:  2018-03-01       Impact factor: 14.919

Review 9.  IKBKAP/ELP1 gene mutations: mechanisms of familial dysautonomia and gene-targeting therapies.

Authors:  Berish Y Rubin; Sylvia L Anderson
Journal:  Appl Clin Genet       Date:  2017-12-15

10.  Retina-specific loss of Ikbkap/Elp1 causes mitochondrial dysfunction that leads to selective retinal ganglion cell degeneration in a mouse model of familial dysautonomia.

Authors:  Yumi Ueki; Veronika Shchepetkina; Frances Lefcort
Journal:  Dis Model Mech       Date:  2018-07-30       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.